The CDC’s Advisory Committee on Immunization Practices (ACIP) recommended an RSV vaccine for pregnant people that would protect infants against the respiratory virus. The vaccine is recommended for use in weeks 32 through 36 of pregnancy, using seasonal administration during September through January.

Sandra Fryhofer, MD, the AMA’s immediate past board chair and liaison to ACIP, joins to discuss the recommendation and its nuances, plus how this maternal RSV vaccine compares to the new monoclonal antibody RSV shot. American Medical Association CXO Todd Unger hosts.

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

📺 Follow the @americanmedicalassociation on YouTube: https://bit.ly/AMA_YouTubeChannel

🎥 Watch #AMAUpdate for the latest in health care news for physicians: https://bit.ly/AMA_Update

📝 Full transcripts of the show are available here: https://bit.ly/AMA_Update_Transcripts

📧 Subscribe to AMA Morning Rounds newsletter, with the news you need every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds

🎧 Listen to our latest podcast episodes now: https://bit.ly/AMA_Podcasts

📲 Download AMA Connect for news, podcasts, video updates and learning in one place: https://apple.co/3URzNES

💬 Connect with the AMA on social media: https://bit.ly/AMA_Social_Media